I Donated My DNA to Help Stop the Coronavirus
By Ronnie S. Stangler,
Medium
| 04. 19. 2020
My personal calculus is that today, collective good trumps individual autonomy.
Last night, I entered intimate personal health information into a database that can be accessed by anyone. This is not a decision that I made lightly. I shared my information with the Personal Genome Project(PGP) at Harvard Medical School. Founded in 2005 by Dr. George Church, the PGP represents an ideal, a vision of effecting ultimate progress in DNA science through the generosity of participants willing to expose personal data for a greater good. Before Covid-19, the PGP used this data for open-source research projects to further our understanding of human genetics, biology, and health. The PGP will now singularly focus on Covid-19, studying both those who have the disease and those who don’t.
Their strategy is uniquely advantaged, as the PGP has already collected its participants’ DNA. Ideally, all subjects who have agreed to participate in this open-source project have already entered all varieties of medical information, from static measures of height, weight, and blood type to information collected over years through contacts with physicians and medical systems.
The grand scheme is to connect genotypes (obtained through...
Related Articles
By Jenny Lange, BioNews | 12.01.2025
A UK toddler with a rare genetic condition was the first person to receive a new gene therapy that appears to halt disease progression.
Oliver, now three years old, has Hunter syndrome, an inherited genetic disorder that leads to physical...
By Rachel Hall, The Guardian | 11.20.2025
Couples are needlessly going through IVF because male infertility is under-researched, with the NHS too often failing to diagnose treatable causes, leading experts have said.
Poor understanding among GPs and a lack of specialists and NHS testing means male infertility...
By Pam Belluck and Carl Zimmer, The New York Times | 11.19.2025
Gene-editing therapies offer great hope for treating rare diseases, but they face big hurdles: the tremendous time and resources involved in devising a treatment that might only apply to a small number of patients.
A study published on Wednesday...
By Aisha Down, The Guardian | 11.10.2025
It has been an excellent year for neurotech, if you ignore the people funding it. In August, a tiny brain implant successfully decoded the inner speech of paralysis patients. In October, an eye implant restored sight to patients who had...
